Literature DB >> 17582546

[Methylphenidate prescriptions in the city of Cologne: overrepresentation of privately insured patients. Results of an analysis based on prescription data].

H Bessou1, H Zeeb, U Puteanus.   

Abstract

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a chronic psychiatric disorder which most commonly affects children and adolescents. Treatment with methylphenidate (MPH) entails a dependency risk as MPH is a psychotropic drug. In Germany, according to pharmaco-epidemiological studies based on figures provided by the general health insurance scheme, MPH prescriptions have increased 40-fold over the past decade.
OBJECTIVE: We aimed to investigate MPH prescriptions issued by medical practitioners in the city of Cologne with a special focus on prescription practices and the proportion of MPH prescriptions issued for privately insured patients.
METHOD: This is a descriptive study. The database consisted of all registered MPH prescriptions during the first two quarters of 2003 and included 2729 prescriptions issued by hospital and practice-based medical practitioners.
RESULTS: 23% of all MPH prescriptions were issued on private prescriptions, indicating an overrepresentation of privately insured patients who generally make up about 10% of all insured persons in Germany. There was a high frequency of once-only prescriptions: 28% of all prescriptions fell into this category. In addition, prescribed daily doses were often lower or higher than age-specific recommended mean daily doses.
CONCLUSION: The study provided evidence of inappropriate care patterns concerning MPH. A marked socio-economic gradient exists with regard to MPH prescriptions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17582546     DOI: 10.1055/s-2007-980181

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  4 in total

1.  Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study.

Authors:  Edeltraut Garbe; Rafael T Mikolajczyk; Tobias Banaschewski; Ulrike Petermann; Franz Petermann; Angela A Kraut; Ingo Langner
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-12       Impact factor: 2.576

2.  The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.

Authors:  Ingrid Schubert; Ingrid Köster; Gerd Lehmkuhl
Journal:  Dtsch Arztebl Int       Date:  2010-09-10       Impact factor: 5.594

3.  General practitioner-centred paediatric primary care reduces risk of hospitalisation for mental disorders in children and adolescents with ADHD: findings from a retrospective cohort study.

Authors:  Angelina Mueller; Olga A Sawicki; Moritz Philipp Günther; Anastasiya Glushan; Claudia Witte; Renate Klaaßen-Mielke; Ferdinand M Gerlach; Martin Beyer; Kateryna Karimova
Journal:  Eur J Gen Pract       Date:  2022-12       Impact factor: 3.636

4.  Prevalence, determinants and spectrum of attention-deficit hyperactivity disorder (ADHD) medication of children and adolescents in Germany: results of the German Health Interview and Examination Survey (KiGGS).

Authors:  Hildtraud Knopf; Heike Hölling; Michael Huss; Robert Schlack
Journal:  BMJ Open       Date:  2012-11-23       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.